Insmed Incorporated has announced that its Chairman of the Board Donald Hayden, Jr is stepping down as chairman and will be replaced by Insmed President and CEO Will Lewis. Hayden, who served as chairman for 13 years, will continue as a director. Former AstraZeneca CEO David Brennan has been elected as lead independent director.
In addition, former Johnson & Johnson executive Elizabeth McKee Anderson is replacing board member Myrtle Potter, who is currently Vant Operating Chair for Roivant Pharma and is on the board of recently launched “vant” Respivant. Anderson currently serves on the boards of a number of biotech organizations, including Aro Biotherapeutics, the Wistar Institute, Bavarian Nordic, and Revolution Medicines.
Lewis said, “The changes we announced today enhance the existing talent of our board and position us for Insmed’s promising future. I am very pleased to welcome Liz to our board, where her extensive experience in global commercial strategy and execution will be invaluable as we advance the US launch of Arikayce and continue to evolve into a commercial-stage company. I would also like to thank Myrtle for her many contributions to Insmed during her tenure. We wish her well in her future endeavors. Finally, I wish to acknowledge Don’s significant contributions and personally thank him for his mentorship and extraordinary leadership over the past 13 years. Through his work as Chairman, Don has helped us become the company we are today. I look forward to working with David Brennan and the entire board as we collectively write the next chapter of Insmed’s future.”
Anderson commented, “I am excited to join Insmed’s board and bring my extensive strategic marketing and market access experience to the company as it executes the launch of Arikayce amikacin liposome inhalation suspension and pursues potential regulatory submissions in Europe and Japan. I look forward to working with the management team and other board members to advance the company’s mission of transforming patients’ lives.”
Read the Insmed press release.
